CURE’s rare cancers page is a go-to resource for oncology news and updates in the world of rare cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in rare cancers.
Patients with neuroendocrine tumors have more treatment options than ever before.
April 18th 2023, 9:00pm
HPV vaccination rates and public knowledge about the connection between the virus and certain cancer types are below what they should be, research found.
April 14th 2023, 7:00pm
After being given 2 years to live by her oncologist, a mother of two children is trying her best to protect her family — and herself — from thinking too negatively despite having rare gastrointestinal cancer.
March 22nd 2023, 6:31pm
This FDA approval of Zynyz was based on findings from a study which demonstrated that the therapy improves responses in patients with locally advanced Merkel cell carcinoma.
March 14th 2023, 9:00pm
The phase 2 DESTINY-PanTumor02 trial included patients with HER2-expressing solid tumors such as bladder, pancreatic and rare tumors.
March 8th 2023, 4:00pm
After being diagnosed with a rare cancer, I met some amazing people and have a new appreciation for life.
March 5th 2023, 6:00pm
When I sit down with my paint brush, despite my cancer history, I don’t feel different anymore.
February 27th 2023, 8:00pm
On multiple occasions, doctors told me not to worry, but I ended up being diagnosed with a rare cancer called leiomyosarcoma.
January 24th 2023, 2:00pm
A phase 2 study will investigate the efficacy of darovasertib for patients with uveal melanoma and whether the drug can potentially result in lower radiation doses or fewer eye removal surgeries.
January 20th 2023, 2:00pm
Lytgobi was approved for pretreated cholangiocarcinoma in September, and updated study findings support the drug’s continued approval.
December 15th 2022, 4:00pm
When Sean Korbitz was a 20-year-old college student, his life trajectory changed with a rare cancer diagnosis, resulting in the removal of 40 tumors; fifteen years later, a new drug made him feel like a “medical miracle.”
Managing Cancer Demands Flexibility and a Strategic Mindset
FDA Grants Full Approval to Vitrakvi For NTRK-Positive Solid Tumors
Kaifan Zhao, AGACNP-BC, PMHNP-BC, Wins CURE’s 2025 Extraordinary Healer® Award
First Patient Dosed in Trial of CT-95 in Mesothelin-Expressing Tumors